Systemic and coronary hemodynamic effects of an amine oxidase inhibitor and of serotonin
- 1 July 1963
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 4 (4) , 467-475
- https://doi.org/10.1002/cpt196344467
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The importance of the monoamine oxidase inhibitors in cardiovascular diseaseThe American Journal of Cardiology, 1960
- BIOCHEMICAL AND PHARMACOLOGICAL EFFECTS OF THE MONOAMINE OXIDASE INHIBITORS, IPRONIAZID, 1-PHENYL-2-HYDRAZINOPROPANE(JB 516) AND 1-PHENYL-3-HYDRAZINOBUTANE(JB 835)1960
- Effect of serotonin (5-hydroxytryptamine) on the systemic and coronary vascular bed of the dogAmerican Journal of Physiology-Legacy Content, 1959
- The application of a monoamine-oxidase inhibitor, 1-phenyl-2-hydrazinopropane (JB-516), to the treatment of primary hypertensionAmerican Heart Journal, 1959
- Effect of Epinephrine and Norepinephrine on Coronary CirculationCirculation Research, 1958
- Einfluss von Isopropyl-isonikotinsäurehydrazid auf den Katecholamingehalt des MyokardsCellular and Molecular Life Sciences, 1958
- BETA-PHENYLISOPROPYLHDRAZINE, A POTENT AND LONG ACTING MONOAMINE OXIDASE INHIBITOR1958
- Assay of Anti-Anginal AgentsCirculation, 1957
- CARCINOID CARDIOVASCULAR DISEASE1956
- ANALYZER FOR ACCURATE ESTIMATION OF RESPIRATORY GASES IN ONE-HALF CUBIC CENTIMETER SAMPLESJournal of Biological Chemistry, 1947